MedTrace Logo

Influenza Management With Polyherbal Formulation

NCT03365336 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-04-11

No results posted yet for this study

Summary

The aim of this study is to determine the efficacy of Flu care polyherbal formulation in the management of acute uncomplicated case of Influenza within 48 hours of symptoms onset.

Conditions

Interventions

DRUG

polyherbal formulation

Each Flu Care consist of 350 mg of polyherbal component

DRUG

Oseltamivir 75mg

All the participant has to take 75 mg of oseltamivir for five days.

Sponsors & Collaborators

  • Composite Interceptive Med Science

    lead INDUSTRY

Principal Investigators

  • Dayanand B Yaligar, MBBS · Narayana Hrudayalaya Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2018-05-15
Completion
2018-05-15

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365336 on ClinicalTrials.gov